Drilldown: Medicines
Appearance
Medicines > classes:
[[:Category:SGLT2_inhibitors|SGLT2 inhibitor]]
& fda max
:
24 mg/day (Parkinson disease); 4 mg/day (restless legs syndrome)
or
5 mg/d 
& fda max
:
24 mg/day (Parkinson disease); 4 mg/day (restless legs syndrome)
or
5 mg/d 
Use the filters below to narrow your results.
There are no results for this report.

